Atorvastatin Calcium
Product Images NDC 53808-1035

6 FDA label images from State Of Florida Doh Central Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53808-1035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image For 10mg (10mg Apotex)

Label Image For 10mg (10mg Apotex)
Label for ATORVASTATIN CALCIUM 10 mg tablets, quantity 30, prescription only. The label indicates packaging by State of Florida DOH Central Pharmacy, located in Tallahassee, FL. It includes a lot number (KN3789), expiration date (08-05-2014), and a UPC barcode.*
FDA Label Image

Label Image For 40mg (40mg Apotex)

Label Image For 40mg (40mg Apotex)
Label for Atorvastatin Calcium 40 mg tablets, quantity of 30 tablets. The label includes lot number KJ7946, expiration date 03/12/2014, and indicates the product is RX only. Packaged by DOH Central Pharmacy, Tallahassee, FL. A barcode and UPC 3605052580093 are also visible.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph comparing the cumulative incidence (%) over approximately 3.5 years between Atorvastatin and Placebo groups. Two lines represent Atorvastatin (solid) and Placebo (dashed), showing lower incidence in the Atorvastatin group. The graph includes a hazard ratio (HR=0.64) with confidence interval (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis represents time in years up to 5 years of follow-up, and the y-axis shows cumulative hazard percentage up to 15%. The graph shows lower cumulative hazard for Atorvastatin versus placebo, with a hazard ratio of 0.63, confidence interval (0.48-0.83), and p-value of 0.001.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over five years for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time in years, and the y-axis shows the percentage of subjects. The graph includes a hazard ratio (HR 0.78) with confidence intervals and p-value, illustrating event occurrence trends between the two dosages.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Atorvastatin Calcium, showing the detailed molecular arrangement including two calcium ions as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.